Sandoz Generic Copaxone Launches At 15% Discount To Teva Brand
This article was originally published in The Pink Sheet Daily
Executive Summary
Federal Circuit tosses Teva's patent, getting around Supreme Court dismissal of its previous ruling by focusing on patent record instead of expert testimony.